Abstract
Objective
To compare the detection rate of clinically significant cancer (CSCa) by magnetic resonance imaging-targeted biopsy (MRI-TB) with that by standard systematic biopsy (SB) and to evaluate the role of MRI-TB as a replacement from SB in men at clinical risk of prostate cancer.
Methods
The non-systematic literature was searched for peer-reviewed English-language articles using PubMed, including the prospective paired studies, where the index test was MRI-TB and the comparator text was SB. Also the randomized clinical trials (RCTs) are included if one arm was MRI-TB and another arm was SB.
Results
Eighteen prospective studies used both MRI-TB and TRUS-SB, and eight RCT received one of the tests for prostate cancer detection. In most prospective trials to compare MRI-TB vs. SB, there was no significant difference in any cancer detection rate; however, MRI-TB detected more men with CSCa and fewer men with CISCa than SB.
Conclusion
MRI-TB is superior to SB in detection of CSCa. Since some significant cancer was detected by SB only, a combination of SB with the TB technique would avoid the underdiagnosis of CSCa.
Similar content being viewed by others
Abbreviations
- COG-TB:
-
Cognitive fusion targeted biopsy
- CSCa:
-
Clinically significant prostate cancer
- CISCa:
-
Clinically insignificant prostate cancer
- CDRs:
-
Cancer detection rates
- GS:
-
Gleason score
- PSA:
-
Prostatic-specific antigen
- RCT:
-
Randomized controlled trial
- SB:
-
Systematic biopsy
- TB:
-
Targeted biopsy
- TRUS:
-
Transrectal ultrasonography
- MRI:
-
Magnetic resonance imaging
- MRUS:
-
Magnetic resonance ultrasonography
References
Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45(1):2–12
de la Rosette JJ, Wink MH, Mamoulakis C et al (2009) Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol. J Urol 182(4):1329–1336. https://doi.org/10.1016/j.juro.2009.06.037
Lui PD, Terris MK, Mcneal JE et al (1995) Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 153(3 Pt 2):1000–1003
Djavan B, Ravery V, Dobronski P et al (2001) Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 166(5):1679–1683
Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MGM (2015) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy : a systematic review and meta-analysis. Eur Urol 68(3):438–450. https://doi.org/10.1016/j.eururo.2014.11.037
Kasivisvanathan V, Stabile A, Neves JB, Giganti F, Novara G (2019) Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis. Eur Urol. https://doi.org/10.1016/j.eururo.2019.04.043
Da Rosa MR, Milot L, Sugar L et al (2015) A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance. J Magn Reson Imaging 41(1):220–225. https://doi.org/10.1002/jmri.24710
Diaz AW, Hoang AN, Turkbey B et al (2020) Can magnetic resonance-ultrasound fusion biopsy improve. J Urol 190(6):2020–2025. https://doi.org/10.1016/j.juro.2013.05.118
Baco E, Ukimura O, Rud E et al (2015) Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol 67(4):787–794. https://doi.org/10.1016/j.eururo.2014.08.077
Rastinehad AR, Turkbey B, Salami SS et al (2014) Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. J Urol 191(6):1749–1754. https://doi.org/10.1016/j.juro.2013.12.007
Delongchamps NB, Portalez D, Bruguière E et al (2016) Are MRI-TRUS-guided targeted biopsies non-inferior to TRUS-guided systematic biopsies for the detection of prostate cancer in patients with a single suspicious focus on multiparametric prostate MRI? Results of a multicentric controlled trial. J Urol. https://doi.org/10.1016/j.juro.2016.04.003
Borkowetz A, Platzek I, Toma M et al (2015) Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. BJU Int 116(6):873–879. https://doi.org/10.1111/bju.13023
Rosario DJ, Walton TJ, Kennish SJ (2018) In-bore multiparametric magnetic resonance imaging targeted biopsy: as good as it gets? Eur Urol 75(4):579–581. https://doi.org/10.1016/j.eururo.2018.12.001
Lee DJ, Recabal P, Sjoberg DD et al (2016) Comparative effectiveness of targeted prostate biopsy using MRI-US fusion software and visual targeting: a prospective study. J Urol. https://doi.org/10.1016/j.juro.2016.03.149
Wegelin O, van Melick HHE, Hooft L, Bosch JLHR, Reitsma HB, Barentsz JO, Somford DM (2017) Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique? Eur Urol 71(4):517–531. https://doi.org/10.1016/j.eururo.2016.07.041
Yamada Y, Fujihara A, Shiraishi T et al (2019) Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: initial experience in Japan. Int J Urol. https://doi.org/10.1111/iju.13924
Ukimura O, Marien A, Palmer S et al (2015) Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies. World J Urol. https://doi.org/10.1007/s00345-015-1501-z
Ukimura O, Desai MM, Palmer S et al (2012) 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. J Urol 187(3):1080–1086. https://doi.org/10.1016/j.juro.2011.10.124
Study PM, Leroy X, Comperat E (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy —prospective multicentre study. Radiology 268(2):461–469. https://doi.org/10.1148/radiol.13121501/-/DC1
Kuru TH, Roethke MC, Seidenader J et al (2013) Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 190(4):1380–1386. https://doi.org/10.1016/j.juro.2013.04.043
Wysock JS, Rosenkrantz AB, Huang WC et al (2014) A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 66(2):343–351. https://doi.org/10.1016/j.eururo.2013.10.048
Sonn GA, Chang E, Natarajan S et al (2014) Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 65(4):809–815. https://doi.org/10.1016/j.eururo.2013.03.025
Mozer P, Rouprêt M, Le CC et al (2015) First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer. BJU Int 115(1):50–57. https://doi.org/10.1111/bju.12690
Quentin M, Blondin D, Arsov C et al (2014) Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy na €ıve men with elevated prostate specific antigen. J Urol 192:1374–1379. https://doi.org/10.1016/j.juro.2014.05.090
Passoni M, Polascik TJ, Parkinson R et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66:22–29. https://doi.org/10.1016/j.eururo.2014.03.002
Maxeiner A, Stephan C, Durmus T, Slowinski T, Cash H, Fischer T (2015) Added value of multiparametric ultrasonography in magnetic resonance. Urology 86(1):108–114. https://doi.org/10.1016/j.urology.2015.01.055
Peyronnet B, De GA, Roupr M et al (2015) Oncology: prostate/testis/penis/urethra accuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinically significant prostate cancer in enlarged compared to smaller prostates. J Urol. https://doi.org/10.1016/j.juro.2015.03.025
Mendhiratta N, Rosenkrantz AB, Meng X et al (2015) Magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in a consecutive cohort of men with no previous biopsy: reduction of over detection through improved risk stratification. J Urol 194(6):1601–1606. https://doi.org/10.1016/j.juro.2015.06.078
Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313(4):390–397. https://doi.org/10.1001/jama.2014.17942
Filson CP, Natarajan S, Margolis DJA, Huang J, Lieu P (2016) Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies. Cancer. https://doi.org/10.1002/cncr.29874
Rouvi O, Delongchamps NB, Portalez D et al (2016) Are magnetic resonance imaging-transrectal ultrasound guided targeted biopsies noninferior to transrectal ultrasound guided systematic biopsies for the detection of prostate cancer? J Urol 196:1069–1075. https://doi.org/10.1016/j.juro.2016.04.003
Jelidi A, Ohana M, Labani A, Alemann G, Lang H, Roy C (2017) Prostate cancer diagnosis: efficacy of a simple electromagnetic MRI-TRUS fusion method to target biopsies. Eur J Radiol 86:127–134. https://doi.org/10.1016/j.ejrad.2016.11.016
Paper O (2017) Urologia a prospective comparison of selective multiparametric magnetic resonance imaging fusion-targeted and systematic transrectal ultrasound-guided biopsies for detecting prostate cancer in men undergoing repeated biopsies. Urol Int 99(4):384–391. https://doi.org/10.1159/000477214
Rouvière O, Puech P, Renard-penna R et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20(1):100–109. https://doi.org/10.1016/S1470-2045(18)30569-2
Elkhoury FF, Feller ER, Kwan L et al (2019) Comparison of targeted vs. systematic prostate biopsy in men who are biopsy naive: the prospective assessment of image registration in the diagnosis of prostate cancer (PAREDCAP) Study. JAMA Surg 154(9):811–818. https://doi.org/10.1001/jamasurg.2019.1734
Kuru TH, Roethke MC, Seidenader J et al (2013) New technology and techniques critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 190:1380–1386. https://doi.org/10.1016/j.juro.2013.04.043
Park BK, Park JW, Park SY et al (2011) Genitourinary imaging original research. Am J Radiol. https://doi.org/10.2214/AJR.11.6829
Arsov C, Rabenalt R, Blondin D et al (2015) Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol 68:713–720. https://doi.org/10.1016/j.eururo.2015.06.008
Baco E, Rud E, Magne L et al (2016) A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur Urol 69(1):149–156. https://doi.org/10.1016/j.eururo.2015.03.041
Taverna G, Bozzini G, Grizzi F et al (2016) Endorectal multiparametric 3-tesla magnetic resonance imaging associated with systematic cognitive biopsies does not increase prostate cancer detection rate: a randomized prospective trial. World J Urol 34(6):797–803. https://doi.org/10.1007/s00345-015-1711-4
Panebianco V, Barchetti F et al (2015) Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol 33(1):17.e1–17.e7. https://doi.org/10.1016/j.urolonc.2014.09.013
Piippo U, Kauppila S, Tonttila PP et al (2016) Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial. Eur Urol 69:419–425. https://doi.org/10.1016/j.eururo.2015.05.024
Porpiglia F, Manfredi M, Mele F et al (2017) Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naïve patients with suspected prostate cancer. Eur Urol 72(2):282–288. https://doi.org/10.1016/j.eururo.2016.08.041
Kassivisvanathan V, Ranniko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378(19):1767–1777. https://doi.org/10.1056/NEJMoa1801993
Rud E, Klotz D, Rennesund K et al (2014) Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114(6b):E32–42. https://doi.org/10.1111/bju.12637
Wegelin O, Exterkate L, Van der Leest M et al (2019) Complications and adverse events of three magnetic resonance imaging-based target biopsy techniques in the diagnosis of prostate cancer among men with prior negative biopsies: results from the FUTURE trial, a multicentre randomised controlled trial. Eur Urol Oncol 2(6):617–624. https://doi.org/10.1016/j.euo.2019.08.007
Connor MJ, Eldred-Evans D, van Son M et al (2020) A multicentre study of the clinical utility of non-targeted systematic transperineal prostate biopsies in patients undergoing pre-biopsy mpMRI. J Urol. https://doi.org/10.1097/JU.0000000000001184
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yamada, Y., Ukimura, O., Kaneko, M. et al. Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) —literature review. World J Urol 39, 677–686 (2021). https://doi.org/10.1007/s00345-020-03366-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-020-03366-x